Login / Signup
Two cases of diabetes mellitus type 1 after alemtuzumab treatment for multiple sclerosis: another probable secondary autoimmune disease.
Stephan Richter
Bert Wagner
Elisabeth Gulowsen Celius
Published in:
Journal of neurology (2019)
Keyphrases
</>
multiple sclerosis
white matter
type diabetes
combination therapy
drug induced
glycemic control
weight loss
replacement therapy